Session I - BURDEN of RSV Disease & Mortality 

Beate Kampmann

Bamenla Goka

Harish Nair

Lawrence Mwananyanda

Ashish Satav

Mauricio Caballero

---

EARLY Career Researchers' Tournament

Emily Phung

Joseph McGinley

Sjanna Besteman

Bryan Nyawanda

---

SESSION II - Latest developments in RSV molecular virology

Ruth Karron

Jason McLellan

Vincente Mas

---

SESSION III - Clinical advancements in RSV treatment

Peter Openshaw

Ann Falsey

---

SESSION IV - clinical advancements and prevention

​​Marta Nunes

Tracy Ruckwardt 

Julia Hurwitz

Alexis Kalergis

---

SESSION V - clinical advancements of rsv treatment

Fernando Polack

Janet Englund

Steve Cunningham

---

SESSION VI - status of rsv therapeutics

Deborah Higgings

Novavax - Greg Glenn

Astra Zeneca - Pam Griffin

Beijing Biotech - Bin Wang

Pfizer - Beate Thoma

Janssen - Esther Heijnen

---

SESSION VII - RSV related recurrent wheeze and asthma

Louis Bont & Heather Zar

Daniel Feikin

Steven Brunwasser

Renato Stein

Eric Simoes

---

SESSION VIII - rsv developing wordl perspectives

James Nokes

Clare Cutland

Timothy Kinyanjui

Natalie Mazur

Alex Dodoo

Rose Jalang'o